Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep303 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Prevalence of sarcopenia with different DXA indices in a population with high-risk obesity

Gonzalez Arnaiz Elena , Gonzalez Roza Lucia , Ramos Bachiller Beatriz , Pintor de la Maza Begona , Barajas-Galindo David , Cano Rodriguez Isidoro , Ballesteros-Pomar Maria

Background: Sarcopenic obesity(SO) is an entity characterized by excess fat mass(FM) and low muscle mass (LMM) and function. Excess FM itself can lead to loss of muscle mass and function at any age. The combination of obesity and sarcopenia is a proven risk factor for frailty, comorbidities and mortality. New diagnostic criteria have been developed for this entity.Aims: To assess the prevalence and severity of SO with different indices by DXA, in a group...

ea0070ep170 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Evaluation of liver fibrosis in patients with diabesity

González Arnáiz Elena , Pintor De la Maza Begoña , González Roza Lucía , Ramos Bachiller Beatriz , Quiñones Castro Raisa , Ariadel Cobo Diana , Barajas Galindo David , Fondo Ana Urioste , Ballesteros Pomar María , Cano Rodriguez Isidoro

Background: NAFLD(non–alcoholic fatty liver disease) includes; non–alcoholic fatty liver(NAFL), non–alcoholic steatohepatitis (NASH) and its complications (fibrosis, cirrhosis and hepatocellular carcinoma). These diseases are currently the most common cause of liver disease in western countries, due to the obesity and DM2 epidemic. There are scores that determine the risk of liver fibrosis in a non–invasive way.Aims: To determine ...